10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,716,932 | +96.5% | 235,562 | +166.0% | 0.01% | +150.0% |
| Q2 2023 | $4,944,855 | +39471.5% | 88,554 | -60.5% | 0.00% | -71.4% |
| Q1 2023 | $12,496 | -71.7% | 223,981 | -81.5% | 0.01% | -70.8% |
| Q4 2022 | $44,216 | -99.3% | 1,213,394 | +467.3% | 0.02% | +500.0% |
| Q3 2022 | $6,092,000 | +54.5% | 213,907 | +145.5% | 0.00% | +100.0% |
| Q2 2022 | $3,942,000 | -73.3% | 87,116 | -55.2% | 0.00% | -75.0% |
| Q1 2022 | $14,782,000 | +41.0% | 194,316 | +176.0% | 0.01% | +60.0% |
| Q4 2021 | $10,487,000 | -63.1% | 70,402 | -55.1% | 0.01% | -75.0% |
| Q1 2021 | $28,394,000 | -40.9% | 156,873 | -53.8% | 0.02% | -42.9% |
| Q4 2020 | $48,068,000 | +611.0% | 339,463 | +526.0% | 0.04% | +337.5% |
| Q3 2020 | $6,761,000 | +19.4% | 54,225 | -40.3% | 0.01% | -38.5% |
| Q1 2020 | $5,664,000 | +196.1% | 90,888 | +262.3% | 0.01% | +550.0% |
| Q4 2019 | $1,913,000 | -21.7% | 25,086 | -48.3% | 0.00% | -50.0% |
| Q3 2019 | $2,444,000 | – | 48,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |